到百度首页
百度首页
濮阳东方医院治疗早泄值得信赖
播报文章

钱江晚报

发布时间: 2025-05-30 23:07:51北京青年报社官方账号
关注
  

濮阳东方医院治疗早泄值得信赖-【濮阳东方医院】,濮阳东方医院,濮阳东方男科收费标准,濮阳东方医院妇科电话咨询,濮阳东方医院男科口碑评价很好,濮阳东方医院男科咨询免费,濮阳东方医院割包皮价格偏低,濮阳东方医院看妇科非常的专业

  

濮阳东方医院治疗早泄值得信赖濮阳东方医院技术可靠,濮阳东方医院男科看早泄技术很哇塞,濮阳市东方医院好,濮阳东方看男科病价格低,濮阳东方男科医院割包皮口碑很好,濮阳东方妇科收费与服务,濮阳东方医院治早泄评价非常好

  濮阳东方医院治疗早泄值得信赖   

BEIJING, Nov. 4 (Xinhuanet) -- The amount of trans fat and other nutritional information will be marked on the labels of prepackaged food, according to the country's first national standard for food nutrition. The labeling will take effect on Jan 1, 2013. "It will help standardize the nutrition facts labeling by food producers and facilitate consumers' rights to know and choose, while improving public awareness of food nutrition," said Yang Yuexin, a senior nutritionist with the Chinese Center for Disease Control and Prevention (CDC). The new regulation by the Ministry of Health stipulates that food labels have to include the food's nutrition information, including levels of energy, protein, fat, carbohydrate and sodium. Food products without proper labels showing the nutritional information will be banned when the new rule takes effect. The new regulation also stipulates that if any hydrogenated or partially hydrogenated fat is used to produce the food, the level of trans fat will have to be highlighted on the nutrition information label. Trans fat is usually produced during food processing when liquid oils are converted into semi-solid fats that help keep food fresh longer. However, the partially hydrogenated oil contains trans fat that can substantially increase the risk of heart disease. However, Zhang Jian, a researcher with CDC's National Institute for Nutrition and Food Safety, said that compared to Western diets, the Chinese diet contains a far lower level of trans fat and there is no need to over react.

  濮阳东方医院治疗早泄值得信赖   

BEIJING, Nov. 13 (Xinhua) -- A campaign that aims to boost the public's role in safeguarding food safety and promote awareness of the issue was launched at the 9th China Food Safety Annual Conference, which closed on Sunday.Food safety has a bearing on people's health as well as the nation's sound and harmonious development, said Shi Xiushi, chairman of the Financial and Economic Committee of China's National People's Congress (NPC), at the opening, calling for efforts to raise companies' sense of responsibility and consumers' awareness in preventing and dealing with food safety crimes.The new campaign is part of a broader five-year program (2011-2015) of food safety education announced by the State Council Food Safety Commission (SCFSC) in May.The program aims for more than 80 percent of the public to be aware of basic food safety by 2015, with the rate for primary and high-school students reaching up to 85 percent or more.ARDUOUS WORKFood safety has become a growing public concern in China following a string of scandals over recent years. In the latest one, illegal workshops were found making and selling "gutter oil," which is processed from leftovers dredged from gutters.Gu Xiulian, former vice chairwoman of the NPC's Standing Committee, the country's top legislature, said ensuring safety is the top priority for the food sector, the country's pillar industry with an output of 550 million yuan (97.3 million U.S. dollars) in the first nine months of 2011.The development of the nation's food safety has failed to keep up with the demands of a public whose living standards have improved substantially in recent years, said Shi.Pledging to do everything it can to ensure food safety, the government takes a zero-tolerance approach to companies that sell unsafe food. In 2010 alone, authorities across the country investigated and handled 130,000 cases of food safety violations, shutting down more than 100,000 companies, according to the SCFSC."The food industry's overall development level is relatively low. There are weak links in the sector's credibility, management, detection techniques and even the laws and regulations," said Pu Changcheng, deputy director of the Administration of Quality Supervision, Inspection and Quarantine.Pu's points are exemplified by China's agricultural industry, which is largely based around small-scale production managed by disparate bodies. It would be a formidable task to eradicate the sector's safety issues.The catering business also faces a similar plight. The country has issued licenses to 2.2 million catering companies, most of which are small and individually operated, making safety supervision extremely difficult, according to Bian Zhenjia, deputy head of the State Food and Drug Administration.

  濮阳东方医院治疗早泄值得信赖   

ROME, Dec. 6 (Xinhua) -- China is playing its part in projects of the United Nations to improve global food security under the framework of South-South Cooperation (SSC), the UN Food and Agriculture Organization (FAO) said on Tuesday.FAO recently co-signed two new tripartite agreements with China, Liberia and Senegal respectively to support implementation of a series of food security initiatives and projects in Liberia and Senegal, the organization said in a press release.The Rome-based food agency said the agreements were signed in the context of the Strategic Alliance between FAO and China on SSC in support of programs for food and nutrition security in selected countries.The funding provided through the new agreement comes from a FAO-China Trust Fund of 30 million U.S. dollars, it said.Under the agreement with Liberia, China will contribute over one million dollars and provide technical assistance through 24 Chinese experts and technicians to support implementation of the country's National Program for Food Security over a two-year period.In Senegal, China will provide assistance through 26 experts and technicians."At a time when continued economic uncertainties are having an impact on the flow of traditional North-South development assistance, South-South Cooperation is creating and building on partnerships that support the direct exchange of financial and technical contributions between developing countries," said Laurent Thomas, FAO Assistant Director-General, Technical Cooperation Department."FAO's experience with South-South Cooperation has shown that the knowledge and skills of technical experts and field technicians from the (global) South have made an invaluable contribution to efforts to modernize small-scale agriculture throughout the developing world," he added.FAO's SSC initiative was launched in 1996 to provide technical support to country-level action on food insecurity.According to the organization, a total of 47 tripartite agreements have been signed to provide technical assistance among developing countries in Africa, Asia-Pacific, Latin America and the Caribbean, and over 1,500 experts and technicians have been fielded in the framework of various food security initiatives.In addition to the Strategic Alliance with China, letters of intent for SSC Strategic Alliance have also been signed so far with Argentina and Indonesia.

  

BEIJING, Dec. 26 (Xinhua) -- The Standing Committee of the National People's Congress (NPC), China's top legislature, began here Monday to deliberate draft interpretations on two annexes of the Basic Law of the Macao concerning election issues.Li Fei, deputy director of the Commission of Legislative Affairs of the NPC Standing Committee, explained the draft interpretations to lawmakers.The Basic Law of the Macao Special Administrative Region (Macao SAR) was adopted in 1993 and went into effect on Dec. 20, 1999.Annex I to the Basic Law provides a method for selecting the SAR's chief executives while Annex II sets the method for the formation of its legislative assembly.Clause 7 of Annex I of the Basic Law says that if there is a need to amend the method for selecting the Chief Executives for 2009, and the terms subsequent to the year 2009, such amendments must be made with endorsement of a two-thirds majority of all the members of the Legislative Council and the consent of the Chief Executive, and they shall be reported to the Standing Committee of the National People's Congress for approval.Clause 3 of Annex II says that if there is a need to amend the method of forming the Legislative Assembly of the Macao Special Administrative Region in and after 2009, such amendments must be made with the endorsement of a two-thirds majority of all the members of the Assembly and the consent of the Chief Executive, and they shall be reported to the Standing Committee of the National People's Congress for the record.Li said that the phase "if there is a need to amend ..." should mean that they may or may not be amended.The decision-making on whether such necessity exists is reserved to the central authorities, or the NPC standing committee, said Li, adding that the Macao SAR government, rather than members of the Legislative Assembly, individually or jointly, should be the proper entity to propose any such amendments.Li also explained that if no amendment to the methods is adopted, the two Annexes should still apply.The full text of draft has not been made public yet, but the points raised by Li are identical to those in the committee's prior interpretations on Hong Kong SAR's Basic Law in 2004.During the deliberation, members of the committee noted that draft would help to safeguard Macao's long-term prosperity and stability.They also believed that it was "proper and necessary" to adopt the draft during this week's session as Macao's chief executive Fernando Chui Sai On had made the issue of modifying the method a "major work" in his policy address for the fiscal year 2012.Chui's statement recognized that "there is agreement that it is appropriate to properly modify the two methods in order to adapt to society's development and progress" and promised to "submit a proposal on whether to modify and - if so - how to modify the methods."Macao expects the formation of its fifth Legislative Assembly in 2013, and the selection of its fourth Chief Executive in 2014.

  

WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday revoked its approval of Avastin for treating the breast cancer after concluding that the drug has not been shown to be safe and effective for that use.Avastin will still remain on the market as an approved treatment for certain types of colon, lung, kidney and brain cancer."After reviewing the available studies it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit, in terms of delay in tumor growth, that would justify those risks," FDA Commissioner Margaret Hamburg said in a statement. "Nor is there evidence that use of Avastin will either help them live longer or improve their quality of life. "Avastin's risks include severe high blood pressure; bleeding and hemorrhaging; heart attack or heart failure; and the development of perforations in different parts of the body such as the nose, stomach, and intestines.Avastin was approved for metastatic breast cancer in February 2008 under the FDA's accelerated approval program, which allows a drug to be approved based on data that are not sufficiently complete to permit full approval. After the approval, the drug's sponsor, Genentech, completed two additional clinical trials and submitted the data from those studies to the FDA. These data showed only a small effect on tumor growth without evidence that patients lived any longer or had a better quality of life compared to taking standard chemotherapy alone -- not enough to outweigh the risk of taking the drug.FDA's Center for Drug Evaluation and Research, which is responsible for the approval of this drug, ultimately concluded that the results of these additional studies did not justify continued approval and notified Genentech it was proposing to withdraw approval of the indication.Genentech did not agree with the Center's evaluation of the data and, following the procedures set out in FDA regulations, requested a hearing on the Center's withdrawal proposal, with a decision to be made by the Commissioner. That two-day hearing, which took place June 28-29, included recommendations from the FDA 's Oncologic Drugs Advisory Committee, voting 6-0 in favor of withdrawing approval of Avastin's breast cancer indication.

举报/反馈

发表评论

发表